Home / Secukinumab / Belgium
BE ATC L04AC10 · updated 2 Nov 2026
Secukinumab shortage in Belgium
Is there a Secukinumab shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Secukinumab product is reported short in Belgium, the first since 26 Oct 2026. The company estimate for the return is 12 Nov 2026. Main reason: manufacturing problem.
Also short in Austria. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Cosentyx 150 mg inj. sol. s.c. pre-filled pen 2 x 1 ml | Novartis Europharm | 26 Oct 2026 | 12 Nov 2026 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.